Pre-Amplification of Cell-Free DNA: Balancing Amplification Errors with Enhanced Sensitivity
Wei Yen Chan(Melanoma Institute Australia), Helen Rizos(Macquarie University), Russell J. Diefenbach(The University of Sydney), Elin S. Gray(Edith Cowan University), Georgina V. Long(The University of Sydney), Ashleigh Stewart(The University of Sydney), Richard A. Scolyer(The University of Sydney), Jenny Lee(Blacktown & Mount Druitt Hospital)
Cited by 0
Related Papers
Nivolumab in Previously Untreated Melanoma without <i>BRAF</i> Mutation
|New England Journal of Medicine|2014|5.3k
Adjuvant Dabrafenib plus Trametinib in Stage III<i>BRAF</i>-Mutated Melanoma
|New England Journal of Medicine|2017|1.5k
Dabrafenib in patients with Val600Glu or Val600Lys BRAF-mutant melanoma metastatic to the brain (BREAK-MB): a multicentre, open-label, phase 2 trial
|The Lancet Oncology|2012|906